Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
Open Access
- 21 July 2010
- journal article
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 3 (1) , 16
Abstract
Background: No data regarding metformin effects on follicular fluid anti-Müllerian hormone (AMH) levels were to date available in literature. The aim of the present study was to evaluate in patients with polycystic ovary syndrome (PCOS) whether metformin administration affects serum and follicular AMH levels, and whether this is related to ovarian response to the treatment. Methods: Twenty young patients with PCOS who had received metformin were enrolled. Ten patients were anovulatory (Met-anov group), whereas the other 10 were ovulatory (Met-ov group) but had failed to conceive. Further untreated PCOS (PCOS controls, n. 10) and healthy controls (non-PCOS controls, n. 10) who were scheduled for laparoscopic surgery were enrolled. In each subjects, clinical and biochemical evaluations were performed. AMH concentrations in blood and antral follicular fluid were assayed. Results: In both Met-anov and Met-ov groups, and without difference between them, serum androgens and AMH, and indices of insulin resistance were significantly (p < 0.05) improved after treatment. On the other hand, significant differences (p < 0.05) between the two groups were detected with respect to the same biochemical parameters in antral follicular fluid. In the Met-anov group, no significant correlation was observed between AMH concentrations in the follicular fluid and variation in serum androgens, AMH and insulin resistance indexes; whereas in Met-ov group significant correlations were detected between AMH levels in the follicular fluid and variation in serum androgens, AMH and insulin resistance indexes. Conclusions: Metformin administration in patients with PCOS exerts a differential action on the ovarian AMH levels on the basis of ovulatory response. Changes in AMH levels in antral follicular fluid during metformin treatment could be involved in the local mechanisms mediating the ovulatory restoration.Keywords
This publication has 30 references indexed in Scilit:
- The effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive ageGynecological Endocrinology, 2010
- Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysisJournal of Ovarian Research, 2009
- Follicle dynamics and anovulation in polycystic ovary syndromeHuman Reproduction Update, 2008
- Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphologyFertility and Sterility, 2007
- Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parametersFertility and Sterility, 2005
- Polycystic Ovary SyndromeNew England Journal of Medicine, 2005
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Ultrasound assessment of the polycystic ovary: international consensus definitionsHuman Reproduction Update, 2003
- Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?Fertility and Sterility, 2000
- Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.BMJ, 1986